Answers are grounded in this paper and cite their sources.
Although adherence to antithrombotic and lipid lowering therapy significantly reduced limb and mortality related outcomes in patients with symptomatic PAD, the PDC remained modest, emphasising the need for strategies to improve long term adherence in this high risk population.
No takes yet. Share an insight, caveat, or question.
Søgaard et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: